When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Soligenix (NASDAQ:SNGX) has opened Phase 1C study to evaluate the safety and immunogenicity of RiVax in healthy, normal adults, followed by a 6-month follow-up period.
More news on: Soligenix, Inc., Healthcare stocks news,